Sequestosome 1: mutation frequencies, haplotypes, and phenotypes in familial Paget's disease of bone
- PMID: 17229007
- DOI: 10.1359/jbmr.06s207
Sequestosome 1: mutation frequencies, haplotypes, and phenotypes in familial Paget's disease of bone
Abstract
Mutations of the SQSTM1/p62 gene are commonly observed in PDB. Screening an updated sample from Quebec and using previously published data from other populations, we compared frequency estimates for SQSTM1/p62 mutations and haplotype distribution. The P392L mutation was the most prevalent, embedded in two different haplotypes, possibly shared by other populations. We also examined the phenotype and penetrance of P392L.
Introduction: There is accumulating evidence that supports a contribution of genetic factors in the etiology of Paget's disease of bone (PDB), and several genetic loci have been suggested for the disorder. The sequestosome1/p62 (SQSTM1/p62) gene was the first gene identified to have a role in PDB, with 14 mutations reported to date.
Material and methods: To evaluate the importance of the SQSTM1/p62 mutations in PDB, we recruited, sequenced, and genotyped a total of 123 carriers from 20 families in addition to 214 unrelated PDB patients. We compared the frequency of SQSTM1/p62 mutations in familial and unrelated cases among different populations. Finally, we examined the phenotypic expression and penetrance of the P392L mutation in the Quebecois families.
Results and conclusions: The 14 mutations reported in SQSTM1/p62 all affect the ubiquitin-associated domain of the protein. The P392L mutation is the most commonly observed mutation in PDB patients and was consistently found in unrelated and familial PDB cases in the populations tested. Analysis of adjacent polymorphisms suggests that P392L is associated with two different haplotypes in the Quebecois patients, similar to what has been observed in European populations. In Quebec, both haplotypes had similar frequencies in unrelated P392L carriers, whereas one haplotype was predominant in the other populations studied. These data suggest that these two haplotypes, possibly introduced by European founders in the Quebecois population, were equally distributed in the succeeding generations. Finally, the P392L mutation is transmitted as an autosomal dominant trait in the Quebecois families, with a high but incomplete penetrance peaking after age 60. The large phenotypic variability and similarity between unrelated and familial cases, respectively, remain unexplained and require further research.
Similar articles
-
Ubiquitin-associated domain mutations of SQSTM1 in Paget's disease of bone: evidence for a founder effect in patients of British descent.J Bone Miner Res. 2005 Feb;20(2):227-31. doi: 10.1359/JBMR.041106. Epub 2004 Nov 16. J Bone Miner Res. 2005. PMID: 15647816
-
Paget's disease of bone in the French population: novel SQSTM1 mutations, functional analysis, and genotype-phenotype correlations.J Bone Miner Res. 2007 Feb;22(2):310-7. doi: 10.1359/jbmr.061106. J Bone Miner Res. 2007. PMID: 17129171
-
Genetic epidemiology of Paget's disease of bone in italy: sequestosome1/p62 gene mutational test and haplotype analysis at 5q35 in a large representative series of sporadic and familial Italian cases of Paget's disease of bone.Calcif Tissue Int. 2009 Jan;84(1):20-37. doi: 10.1007/s00223-008-9192-8. Epub 2008 Dec 9. Calcif Tissue Int. 2009. PMID: 19067022
-
Genetic aspects of the Paget's disease of bone: concerns on the introduction of DNA-based tests in the clinical practice. Advantages and disadvantages of its application.Eur J Clin Invest. 2010 Jul;40(7):655-67. doi: 10.1111/j.1365-2362.2010.02312.x. Eur J Clin Invest. 2010. PMID: 20658751 Review.
-
New insights into the role of sequestosome 1/p62 mutant proteins in the pathogenesis of Paget's disease of bone.Endocr Rev. 2013 Aug;34(4):501-24. doi: 10.1210/er.2012-1034. Epub 2013 Apr 23. Endocr Rev. 2013. PMID: 23612225 Review.
Cited by
-
Updates on Paget's Disease of Bone.Endocrinol Metab (Seoul). 2022 Oct;37(5):732-743. doi: 10.3803/EnM.2022.1575. Epub 2022 Oct 25. Endocrinol Metab (Seoul). 2022. PMID: 36327984 Free PMC article.
-
Paget's disease: epidemiology and pathophysiology.Curr Osteoporos Rep. 2008 Dec;6(4):125-9. doi: 10.1007/s11914-008-0022-8. Curr Osteoporos Rep. 2008. PMID: 19032921
-
Epidemiology of Paget's disease of bone in the city of Recife, Brazil.Rheumatol Int. 2012 Oct;32(10):3087-91. doi: 10.1007/s00296-011-2092-7. Epub 2011 Sep 14. Rheumatol Int. 2012. PMID: 21915757
-
Diagnosis and treatment of Paget's disease of bone: position paper from the Italian Society of Osteoporosis, Mineral Metabolism and Skeletal Diseases (SIOMMMS).J Endocrinol Invest. 2024 Jun;47(6):1335-1360. doi: 10.1007/s40618-024-02318-1. Epub 2024 Mar 15. J Endocrinol Invest. 2024. PMID: 38488978 Free PMC article. Review.
-
The LIM protein LIMD1 influences osteoblast differentiation and function.Exp Cell Res. 2008 Sep 10;314(15):2884-94. doi: 10.1016/j.yexcr.2008.06.003. Epub 2008 Jun 9. Exp Cell Res. 2008. PMID: 18657804 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical